The virtual laboratory approach to pharmacokinetics: design principles and concepts
- PMID: 16935747
- DOI: 10.1016/j.drudis.2006.07.001
The virtual laboratory approach to pharmacokinetics: design principles and concepts
Abstract
Modeling and simulation in pharmacokinetics has turned into the focus of pharmaceutical companies, driven by the emerging consensus that in silico predictions, combined with in vitro data, have the potential to significantly increase insight into pharmacokinetic processes. To support in silico methodology adequately, software tools need to be user-friendly and, at the same time, flexible. In brief, the software has to allow the modeling of ideas that go beyond the current knowledge--in the form of a virtual laboratory. In this review, we present and discuss the necessary design principles and concepts required to do this. They have been implemented in the software package MEDICI-PK, demonstrating its feasibility and advantages.
Similar articles
-
Application of full physiological models for pharmaceutical drug candidate selection and extrapolation of pharmacokinetics to man.Basic Clin Pharmacol Toxicol. 2005 Mar;96(3):193-9. doi: 10.1111/j.1742-7843.2005.pto960308.x. Basic Clin Pharmacol Toxicol. 2005. PMID: 15733214
-
A4S: a user-friendly graphical tool for pharmacokinetic and pharmacodynamic (PK/PD) simulation.Comput Methods Programs Biomed. 2013 May;110(2):203-14. doi: 10.1016/j.cmpb.2012.10.006. Epub 2012 Nov 20. Comput Methods Programs Biomed. 2013. PMID: 23182621
-
Study design and simulation approach.Handb Exp Pharmacol. 2011;205:125-48. doi: 10.1007/978-3-642-20195-0_6. Handb Exp Pharmacol. 2011. PMID: 21882109
-
Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research.Trends Pharmacol Sci. 2008 Apr;29(4):186-91. doi: 10.1016/j.tips.2008.01.007. Epub 2008 Mar 18. Trends Pharmacol Sci. 2008. PMID: 18353445 Review.
-
Integration of in silico and in vitro platforms for pharmacokinetic-pharmacodynamic modeling.Expert Opin Drug Metab Toxicol. 2010 Sep;6(9):1063-81. doi: 10.1517/17425255.2010.496251. Expert Opin Drug Metab Toxicol. 2010. PMID: 20540627 Review.
Cited by
-
A systems biology approach to dynamic modeling and inter-subject variability of statin pharmacokinetics in human hepatocytes.BMC Syst Biol. 2011 May 6;5:66. doi: 10.1186/1752-0509-5-66. BMC Syst Biol. 2011. PMID: 21548957 Free PMC article.
-
A STELLA simulation model for in vitro dissolution testing of respirable size particles.Sci Rep. 2019 Dec 6;9(1):18522. doi: 10.1038/s41598-019-55164-0. Sci Rep. 2019. PMID: 31811249 Free PMC article.
-
Explicit reformulations of the Lambert W-omega function for calculations of the solutions to one-compartment pharmacokinetic models with Michaelis-Menten elimination kinetics.Eur J Drug Metab Pharmacokinet. 2011 Sep;36(3):121-7. doi: 10.1007/s13318-011-0040-2. Epub 2011 May 1. Eur J Drug Metab Pharmacokinet. 2011. PMID: 21533844
-
Improved biological properties and hypouricemic effects of uricase from Candida utilis loaded in novel alkaline enzymosomes.Int J Nanomedicine. 2012;7:3929-38. doi: 10.2147/IJN.S33835. Epub 2012 Jul 23. Int J Nanomedicine. 2012. PMID: 22915844 Free PMC article.
-
Agent-based modeling: a systematic assessment of use cases and requirements for enhancing pharmaceutical research and development productivity.Wiley Interdiscip Rev Syst Biol Med. 2013 Jul-Aug;5(4):461-80. doi: 10.1002/wsbm.1222. Epub 2013 Jun 4. Wiley Interdiscip Rev Syst Biol Med. 2013. PMID: 23737142 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources